The influences of cholecystectomy on the circadian rhythms of bile acids as well as the enterohepatic transporters and enzymes systems in mice

References

• Amigo L, Husche C, Zanlungo S, Lutjohann D, Arrese M, Miquel JF, Rigotti A, Nervi F. 2011. Cholecystectomy increases hepatic triglyceride content and very-low-density lipoproteins production in mice. Liver Int off J Int Assoc Study Liver 31:52–64. doi:10.1111/j.1478-3231.2010.02361.x.
   PubMed Web of Science ®Google Scholar
• Brown AJ, Sharpe LJ. 2016. Bile acid metabolism. In McLeod NDRS, editor. Biochemistry of lipids, lipoproteins and membranes, 6th Edn. Boston: Elsevier. p. 359–89.
   Google Scholar
• Chen J, Zhao KN, Chen C. 2014. The role of CYP3A4 in the biotransformation of bile acids and therapeutic implication for cholestasis. Ann Trans Med 2:7. doi:10.3978/j.issn.2305-5839.2013.03.02.
   PubMedGoogle Scholar
• de Aguiar Vallim TQ, Tarling EJ, Edwards PA. 2013. Pleiotropic roles of bile acids in metabolism. Cell Metab 17:657–69. doi:10.1016/j.cmet.2013.03.013.
   PubMed Web of Science ®Google Scholar
• Eggink HM, Oosterman JE, de Goede P, de Vries EM, Foppen E, Koehorst M, Groen AK, Boelen A, Romijn JA, la Fleur SE, et al. 2017. Complex interaction between circadian rhythm and diet on bile acid homeostasis in male rats. Chronobiol Int 1–15. doi:10.1080/07420528.2017.1363226.
   Web of Science ®Google Scholar
• Froy O. 2009. Cytochrome P450 and the biological clock in mammals. Curr Drug Metab 10:104–15.
   PubMed Web of Science ®Google Scholar
• Gachon F, Firsov D. 2011. The role of circadian timing system on drug metabolism and detoxification. Expert Opin Drug Metab Toxicol 7:147–58. doi:10.1517/17425255.2011.544251.
   PubMed Web of Science ®Google Scholar
• Govindarajan K, MacSharry J, Casey PG, Shanahan F, Joyce SA, Gahan CG. 2016. Unconjugated bile acids influence expression of circadian genes: a potential mechanism for microbe-host crosstalk. PloS One 11:e0167319. doi:10.1371/journal.pone.0167319.
   PubMed Web of Science ®Google Scholar
• Halilbasic E, Claudel T, Trauner M. 2013. Bile acid transporters and regulatory nuclear receptors in the liver and beyond. J Hepatol 58:155–68. doi:10.1016/j.jhep.2012.08.002.
   PubMed Web of Science ®Google Scholar
• Housset C, Chretien Y, Debray D, Chignard N. 2016. Functions of the gallbladder. Compr Physiol 6:1549–77. doi:10.1002/cphy.c150050.
   PubMed Web of Science ®Google Scholar
• Jonker JW, Liddle C, Downes M. 2012. FXR and PXR: Potential therapeutic targets in cholestasis. J Steroid Biochem Mol Biol 130:147–58. doi:10.1016/j.jsbmb.2011.06.012.
   PubMed Web of Science ®Google Scholar
• Kim I, Ahn SH, Inagaki T, Choi M, Ito S, Guo GL, Kliewer SA, Gonzalez FJ. 2007. Differential regulation of bile acid homeostasis by the farnesoid X receptor in liver and intestine. J Lipid Res 48:2664–72. doi:10.1194/jlr.M700330-JLR200.
   PubMed Web of Science ®Google Scholar
• Kuipers F, Bloks VW, Groen AK. 2014. Beyond intestinal soap-bile acids in metabolic control. Nat Rev Endocrinol 10:488–98. doi:10.1038/nrendo.2014.60.
   PubMed Web of Science ®Google Scholar
• Lefebvre P, Cariou B, Lien F, Kuipers F, Staels B. 2009. Role of bile acids and bile acid receptors in metabolic regulation. Physiol Rev 89:147–91. doi:10.1152/physrev.00010.2008.
   PubMed Web of Science ®Google Scholar
• Li T, Chiang JY. 2013. Nuclear receptors in bile acid metabolism. Drug Metab Rev 45:145–55. doi:10.3109/03602532.2012.740048.
   PubMed Web of Science ®Google Scholar
• Li T, Chiang JY. 2014. Bile acid signaling in metabolic disease and drug therapy. Pharmacol Rev 66:948–83. doi:10.1124/pr.113.008201.
   PubMed Web of Science ®Google Scholar
• Li T, Francl JM, Boehme S, Ochoa A, Zhang Y, Klaassen CD, Erickson SK, Chiang JY. 2012. Glucose and insulin induction of bile acid synthesis: Mechanisms and implication in diabetes and obesity. J Biol Chem 287:1861–73. doi:10.1074/jbc.M111.305789.
   PubMed Web of Science ®Google Scholar
• Lu YF, Jin T, Xu Y, Zhang D, Wu Q, Zhang YK, Liu J. 2013. Sex differences in the circadian variation of cytochrome p450 genes and corresponding nuclear receptors in mouse liver. Chronobiol Int 30:1135–43. doi:10.3109/07420528.2013.805762.
   PubMed Web of Science ®Google Scholar
• Ma K, Xiao R, Tseng HT, Shan L, Fu L, Moore DD. 2009. Circadian dysregulation disrupts bile acid homeostasis. PloS One 4:e6843. doi:10.1371/journal.pone.0006843.
   PubMed Web of Science ®Google Scholar
• Nervi F, Arrese M. 2013. Cholecystectomy and NAFLD: Does gallbladder removal have metabolic consequences? Am J Gastroenterol 108:959–961. doi:10.1038/ajg.2013.84.
   PubMedGoogle Scholar
• Reinke H, Asher G. 2016. Circadian clock control of liver metabolic functions. Gastroenterology 150:574–80. doi:10.1053/j.gastro.2015.11.043.
   PubMed Web of Science ®Google Scholar
• Ridlon JM, Wolf PG, Gaskins HR. 2016. Taurocholic acid metabolism by gut microbes and colon cancer. Gut Microbes 1–15. doi:10.1080/19490976.2016.1150414.
   Web of Science ®Google Scholar
• Ruhl CE, Everhart JE. 2013. Relationship of non-alcoholic fatty liver disease with cholecystectomy in the US population. Am J Gastroenterol 108:952–58. doi:10.1038/ajg.2013.70.
   PubMed Web of Science ®Google Scholar
• Sayin SI, Wahlstrom A, Felin J, Jantti S, Marschall HU, Bamberg K, Angelin B, Hyotylainen T, Oresic M, Backhed F. 2013. Gut microbiota regulates bile acid metabolism by reducing the levels of tauro-beta-muricholic acid, a naturally occurring FXR antagonist. Cell Metab 17:225–35. doi:10.1016/j.cmet.2013.01.003.
   PubMed Web of Science ®Google Scholar
• Siddiqui AA, Kedika R, Mahgoub A, Patel M, Cipher DJ, Bapat V. 2009. A previous cholecystectomy increases the risk of developing advanced adenomas of the colon. South Med J 102:1111–15. doi:10.1097/SMJ.0b013e3181b85063.
   PubMed Web of Science ®Google Scholar
• Thakkar N, Slizgi JR, Brouwer KLR. 2017. Effect of liver disease on hepatic transporter expression and function. J Pharm Sci doi:10.1016/j.xphs.2017.04.053.
   PubMed Web of Science ®Google Scholar
• Trauner M, Claudel T, Fickert P, Moustafa T, Wagner M. 2010. Bile acids as regulators of hepatic lipid and glucose metabolism. Dig Dis 28:220–24. doi:10.1159/000282091.
   PubMed Web of Science ®Google Scholar
• Werk AN, Cascorbi I. 2014. Functional gene variants of CYP3A4. Clin Pharmacol Ther 96:340–48. doi:10.1038/clpt.2014.129.
   PubMed Web of Science ®Google Scholar
• Zhang F, Qin H, Zhao Y, Wei Y, Xi L, Rao Z, Zhang J, Ma Y, Duan Y, Wu X. 2017. Effect of cholecystectomy on bile acids as well as relevant enzymes and transporters in mice: Implication for pharmacokinetic changes of rifampicin. Eur J Pharm Sci 96:141–53. doi:10.1016/j.ejps.2016.09.006.
   PubMed Web of Science ®Google Scholar
• Zhang YK, Guo GL, Klaassen CD. 2011. Diurnal variations of mouse plasma and hepatic bile acid concentrations as well as expression of biosynthetic enzymes and transporters. PloS One 6:e16683. doi:10.1371/journal.pone.0016683.
   PubMed Web of Science ®Google Scholar
• Zhou H, Hylemon PB. 2014. Bile acids are nutrient signaling hormones. Steroids 86:62–68. doi:10.1016/j.steroids.2014.04.016.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li F, Guo GL. 2011. Tissue-specific function of farnesoid X receptor in liver and intestine. Pharmacol Res off J Italian Pharmacol Soc 63:259–65. doi:10.1016/j.phrs.2010.12.018.
   PubMed Web of Science ®Google Scholar